- Home
- CMMB vs BLIN Comparison
CMMB vs BLIN Comparison
Compare CMMB & BLIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- BLIN
- Stock Information
- Founded
- CMMB 2004
- BLIN 2000
- Country
- CMMB Israel
- BLIN United States
- Employees
- CMMB N/A
- BLIN N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- BLIN EDP Services
- Sector
- CMMB Health Care
- BLIN Technology
- Exchange
- CMMB Nasdaq
- BLIN Nasdaq
- Market Cap
- CMMB 13.8M
- BLIN 15.9M
- IPO Year
- CMMB N/A
- BLIN 2007
- Fundamental
- Price
- CMMB $2.54
- BLIN $0.97
- Analyst Decision
- CMMB Strong Buy
- BLIN Strong Buy
- Analyst Count
- CMMB 2
- BLIN 1
- Target Price
- CMMB $26.50
- BLIN $4.62
- AVG Volume (30 Days)
- CMMB 80.5K
- BLIN 44.8K
- Earning Date
- CMMB 11-20-2025
- BLIN 12-22-2025
- Dividend Yield
- CMMB N/A
- BLIN N/A
- EPS Growth
- CMMB N/A
- BLIN N/A
- EPS
- CMMB N/A
- BLIN N/A
- Revenue
- CMMB N/A
- BLIN $15,375,000.00
- Revenue This Year
- CMMB N/A
- BLIN $2.45
- Revenue Next Year
- CMMB N/A
- BLIN $16.36
- P/E Ratio
- CMMB N/A
- BLIN N/A
- Revenue Growth
- CMMB N/A
- BLIN 0.54
- 52 Week Low
- CMMB $2.36
- BLIN $0.90
- 52 Week High
- CMMB $9.84
- BLIN $2.80
- Technical
- Relative Strength Index (RSI)
- CMMB 42.45
- BLIN 33.16
- Support Level
- CMMB $2.36
- BLIN $0.92
- Resistance Level
- CMMB $2.85
- BLIN $1.00
- Average True Range (ATR)
- CMMB 0.20
- BLIN 0.07
- MACD
- CMMB -0.02
- BLIN -0.01
- Stochastic Oscillator
- CMMB 32.71
- BLIN 26.63
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.
About BLIN Bridgeline Digital Inc.
Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.